わかもと製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4512/E00928 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2019/09/13 | 日証協 | 301,600株 | -0.76% | 120,531株 | -46.45% | 480,224株 | -0.15% | 8,200株 | -26.79% |
2019/09/06 | 日証協 | 303,909株 | -0.33% | 225,100株 | -7.87% | 480,933株 | -0.85% | 11,200株 | -57.25% |
2019/08/30 | 日証協 | 304,921株 | -1.2% | 244,324株 | -20.67% | 485,033株 | +2.3% | 26,200株 | +29.7% |
2019/08/23 | 日証協 | 308,609株 | -1.53% | 308,000株 | +41.54% | 474,133株 | +1.93% | 20,200株 | +53.03% |
2019/08/16 | 日証協 | 313,409株 | -1.69% | 217,600株 | +409.6% | 465,133株 | +1.79% | 13,200株 | -50% |
2019/08/09 | 日証協 | 318,809株 | +6.52% | 42,700株 | -82.21% | 456,933株 | +2.91% | 26,400株 | +214.29% |
2019/08/02 | 日証協 | 299,309株 | +1.66% | 240,000株 | +329.34% | 444,033株 | +0.57% | 8,400株 | -26.32% |
2019/07/26 | 日証協 | 294,409株 | -2.26% | 55,900株 | -73.9% | 441,533株 | -2.5% | 11,400株 | -27.39% |
2019/07/19 | 日証協 | 301,209株 | +6.13% | 214,200株 | +387.93% | 452,833株 | +4.07% | 15,700株 | -52.57% |
2019/07/12 | 日証協 | 283,809株 | +2.64% | 43,900株 | -86.74% | 435,133株 | +4.32% | 33,100株 | -0.9% |
2019/07/05 | 日証協 | 276,509株 | +1.58% | 331,000株 | +410.02% | 417,133株 | -2.09% | 33,400株 | -58.2% |
2019/06/28 | 日証協 | 272,209株 | +7.67% | 64,900株 | +101.55% | 426,034株 | +5.71% | 79,900株 | +105.93% |
2019/06/21 | 日証協 | 252,809株 | -6.89% | 32,200株 | -90.43% | 403,034株 | -2.61% | 38,800株 | +48.66% |
2019/06/14 | 日証協 | 271,509株 | +0.04% | 336,300株 | +83.27% | 413,834株 | +1.42% | 26,100株 | +18.64% |
2019/06/07 | 日証協 | 271,409株 | +11.5% | 183,500株 | +89.96% | 408,034株 | +3.37% | 22,000株 | -77.8% |
2019/05/31 | 日証協 | 243,409株 | +24.18% | 96,600株 | -52.3% | 394,734株 | +28.73% | 99,100株 | +114.04% |
2019/05/24 | 日証協 | 196,009株 | +13.43% | 202,500株 | +114.74% | 306,634株 | +5.69% | 46,300株 | +86.69% |
2019/05/17 | 日証協 | 172,809株 | +18.44% | 94,300株 | +47.57% | 290,134株 | +27.23% | 24,800株 | -65.36% |
2019/05/10 | 日証協 | 145,909株 | +0.97% | 63,900株 | -25.87% | 228,034株 | -0.22% | 71,600株 | +205.98% |
※株式分割は考慮していませんのでご注意ください。
Page Top